EDIT FY 2023 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$78M+296.3% YoY

Gross Profit

$72M92.2% margin

Operating Income

-$169M-216.6% margin

Net Income

-$153M-196.1% margin

EPS (Diluted)

$-2.02

Cash Flow

Operating Cash Flow

-$132M

Free Cash Flow

-$137M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$499M

Total Liabilities

$150M

Stockholders' Equity

$349M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$78M	$20M	+296.3%
Gross Profit	$72M	$13M	+438.8%
Operating Income	-$169M	-$226M	+25.1%
Net Income	-$153M	-$220M	+30.5%